Solid Biosciences Inc Dette/Equité
Quel est le Dette/Equité de Solid Biosciences Inc?
Le Dette/Equité de Solid Biosciences Inc est 0.30
Quelle est la définition de Dette/Equité?
Le ratio d'endettement et d'équité est un ratio financier indiquant la proportion relative des capitaux propres et de la dette utilisée pour financer les actifs d'une entreprise.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Dette/Equité des entreprises dans Health Care secteur sur NASDAQ par rapport à Solid Biosciences Inc
Que fait Solid Biosciences Inc?
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
Entreprises avec dette/equité similaire à Solid Biosciences Inc
- West Fraser Timber Co a Dette/Equité de 0.30
- West Fraser Timber Co a Dette/Equité de 0.30
- Radcom a Dette/Equité de 0.30
- Lancaster Colony a Dette/Equité de 0.30
- Ikonics a Dette/Equité de 0.30
- Riddhi Siddhi Gluco Biols a Dette/Equité de 0.30
- Solid Biosciences Inc a Dette/Equité de 0.30
- Infibeam Avenues a Dette/Equité de 0.30
- TDG Gold a Dette/Equité de 0.30
- Motif Bio plc a Dette/Equité de 0.30
- Matinas Biopharma Inc a Dette/Equité de 0.30
- Sun.King Power Electronics a Dette/Equité de 0.30
- Yunji a Dette/Equité de 0.30